HopeStage
Back to all studies
CompletedNCT00169065

Clozapine compared with olanzapine for treatment-resistant schizophrenia

About this titleRead the official source — NCT00169065
Medication studyAges 20–60United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 20 years to 60 years.

Listed locations
Jamaica PlainSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 1998
Recruitment status
Completed
Enrollment listed in the registry
38
Sponsor
Harvard Medical School (HMS and HSDM)
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 20 Years to 60 Years
Official registry ID
NCT00169065
Official title
Show the full official title

Clozapine vs. Olanzapine: An Effectiveness Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Jamaica Plain

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Harvard Medical School (HMS and HSDM).

Did this study involve medication?

Yes. The study involved medication, including Clozapine and Olanzapine.

Who was this study for?

Listed age limits: 20 years to 60 years.

Want to explore more studies?

Explore studies